Edward Filippone is a Nephrology physician affiliated with Thomas Jefferson University. OpenAlex indexes 79 publications with 1,723 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
2228 S Broad St
Phila, PA 191453923
Telephone
215-467-8955Registry record last updated 15 Sept 2016.
Industry payments
24 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year202537 payments$40,171openpaymentsdata.cms.gov ↗
- Boehringer Ingelheim Pharmaceuticals, Inc.Program year20258 payments
- Otsuka Pharmaceutical Development & Commercialization, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
64.3%Calcium channel blocker14.2%Amlodipine Besylate89%Nifedipine Er11%Part D≥101 patientsAngiotensin receptor blocker (ARB)10.3%Losartan Potassium88%Olmesartan Medoxomil9%Valsartan3%Part D<11 patients+ 10 more classes in this area
Metabolism & gastrointestinal
27%SGLT2 inhibitor18.6%Jardiance78%Farxiga20%Dapagliflozin2%Part D<11 patientsPotassium supplement2.8%Potassium Chloride72%Klor-Con M2028%Part D<11 patients+ 6 more classes in this area
Blood & clotting
2.6%Solutions for parenteral nutrition1.6%Calcium Acetate100%Part D≥24 patientsFactor Xa inhibitor0.5%Eliquis100%Part D<11 patients+ 1 more class in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Opportunities and Limitations of Renal Denervation: Where Do We Stand?
The American Journal of Medicine
2024 - Controversies in Hypertension III: Dipping, Nocturnal Hypertension, and the Morning Surge
The American Journal of Medicine
2023 - Controversies in Hypertension V: Resistant and Refractory Hypertension
The American Journal of Medicine
2023
Similar KOLs
Other experts from the same institution or the same specialty.
Carol Shields, MD
Thomas Jefferson University
Joseph Bavaria, MD
Thomas Jefferson University
Michele Meltzer, MD
Thomas Jefferson University
Marinos Dalakas, MD
Thomas Jefferson University
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”